Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2004, p. 3662-3669, Vol. 48, No. 10
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.10.3662-3669.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Institut National de la Santé et de la Recherche Médicale, Unité 595,1 Faculté de Chirurgie Dentaire, Université Louis Pasteur,2 Institut Charles Sadron, UPR 22 CNRS, Strasbourg,4 Entomed SA, Illkirch, France3
Received 10 February 2004/ Returned for modification 25 May 2004/ Accepted 20 June 2004
|
|
|---|
|
|
|---|
The initial step of infection is always linked to the ability of the bacteria to adhere to material surfaces (26). Even if the adhesion is initially reversible, it becomes irreversible later, during the infectious process. In fact, the association of the individual microorganisms and matrix formation lead to an organized and protected structure, the slime, which has a high level of resistance to conventional antibiotic therapy. The increasing problem of bacterial resistance (32, 38) has stimulated growing interest in the development of antimicrobial peptides as new therapeutic agents. Antimicrobial peptides were first discovered in insects and were then reported to exist also in mammals and plants (19). They participate in the innate immune defense against microorganisms. One of the first targets of antimicrobial peptides is the bacterial membrane. Therefore, to develop resistance, a microorganism would have to redesign its membrane structure, changing the composition and/or organization of its lipids, which represents a costly solution for most microbial species. In addition, multicellular organisms fight microorganisms with a large variety of antimicrobial peptides of different structural classes and with different spectra of action.
In the study described here, we have immobilized an antimicrobial peptide, the defensin from Anopheles gambiae mosquitoes, onto a planar substrate by embedding it in multilayer films. Insect defensins are members of a widely distributed family of antibacterial peptides with a typical pattern of six cysteine residues and three disulfide bridges. These peptides are made up of 36 to 46 amino acids and are active against a wide range of gram-positive bacteria and some gram-negative bacteria (such as E. coli D22). Fungi and yeasts were also reported to be affected by defensins (4). Although the detailed mechanism of action of the defensins is not fully understood at present, patch-clamp experiments with giant liposomes support the hypothesis that defensins affect the permeability of the bacterial membrane through the formation of channels in the cytoplasmic membrane (8). This mode of action, with no intracellular target, seemed of interest for the creation of a surface with antimicrobial properties by means of immobilization with defensins.
The main limitation in the development of antimicrobial peptides as therapeutic agents is that although many naturally occurring peptides are active in vitro, they are effective in infected animal models only at very high doses, close to the toxic doses of the peptide (11). Thus, most pharmaceutical strategies have been devoted to the development of agents for topical applications, largely because of the relative safety of topical therapy and the uncertainty surrounding the long-term toxicology of any new class of drug administered systemically (15). An approach to controlling unwanted biofilm formation at the surface of implanted materials is to kill the bacteria during their initial attachment rather than trying to remove them once they have adhered. In this context, we report here on a new approach consisting of simply embedding antimicrobial peptides into multilayer polyelectrolyte films, with the aim being to isolate the peptides while retaining their bioactivities. Interestingly, these films, based on the alternate deposition of oppositely charged polyelectrolyte layers (Fig. 1A), are able to coat any type of surface (e.g., metals and plastics) (12) without any shape limitation (e.g., planar, spherical, or curved) (36). Functionalization of the multilayer films can be accomplished by insertion of peptides or proteins inside the film (Fig. 1B). On the basis of these objectives, the layer-by-layer technique was recently developed with the aim of using it for different biological applications in the fields of biosensors (6), cell signaling control (7), and antiadhesive surfaces (2). To our knowledge, this study is the first one to use the layer-by-layer technique and simple peptide adsorption to provide antimicrobial protection.
![]() View larger version (40K): [in a new window] |
FIG. 1. Schematic of polyelectrolyte multilayer film (A) and defensin insertion (B). Adsorption is obtained by adding a layer of the opposite charge; the peptide is embedded under another polyelectrolyte layer.
|
|
|
|---|
Defensin was kindly provided by Entomed SA in dehydrated form and has the following amino acid sequence: ATCDLASGFGVGSSLCAAHCIARRYRGGYCNSKAVCVCRN. This peptide exhibits a high degree of identity and a conserved length compared to those of other insect defensins. The peptide has a pI of about 10, and the protein is positively charged at our working pH (6.5 to 7). The peptide was therefore always adsorbed on top of a PGA layer from a solution of 10 µM in 0.15 M NaCl and was further covered with a PLL layer. Two types of buildup were investigated: PEI-(PSS-PAH)2-PGA-PLL-(PGA-defensin-PLL)n (where n corresponds to the number of PGA-defensin-PLL layers) for films in which the final layer is PLL and PEI-(PSS-PAH)2-PGA-PLL-(PGA-defensin-PLL)n-PGA for films in which the final layer is PGA. Films in which n corresponded to 1, 2, 5, and 10 were investigated by the antimicrobial assays.
Bacterial growth assay.
Two bacterial strains were used for the antimicrobial assays: E. coli D22 (a gift of P. Bocquet, Centre d'Etude Nucléaire, Saclay, France) and Micrococcus luteus (a gift of P. Bulet, UPR CNRS 9022). They were grown aerobically in Luria-Bertani broth (LB) medium at 37°C for E. coli and 30°C for M. luteus. The bacteria were harvested at mid-exponential growth phase and diluted to an optical density at 600 nm (OD600) of 0.001 in a poor broth (PB) medium in order to slow the bacterial growth. Experiments were done in 96-well plates (Nunc), with 100 µl of bacterial growth medium deposited in each well. The peripheral wells were always filled with 100 µl of PB medium in order to decrease the uncertainties in the results due to the high level of evaporation from the wells; they also served as controls for contamination. After 16 h of incubation under agitation (40 rpm) at 37°C for E. coli and 30°C for M. luteus, the bacterial growth was measured with a Metertech
960 spectrometer at 600 nm.
Bacterial adherence assay. Two E. coli strains were transformed by electroporation with either a plasmid bearing green fluorescent protein (GFP) gene mut3 under the control of the Salmonella enterica serovar Typhimurium ribosomal protein promoter (a gift of B. Lemaitre) or a plasmid bearing the red fluorescent protein (RFP) from a Discosoma sp. (Clontech Laboratories, Inc.). The transformed bacteria expressing GFP or RFP were grown aerobically in LB and selected with ampicillin. For the initial adhesion assays, GFP-expressing bacteria were diluted to an OD600 of 0.01 in LB and plated on the polyelectrolyte multilayers. After 30 min of adhesion, they were rinsed three times with phosphate-buffered saline.
Confocal laser scanning microscopy (CLSM). PLL conjugated to fluorescein isothiocyanate (PLL-FITC) and PGA conjugated to Texas Red (PGA-TR) were used to image the dye-labeled film in the green and red channels. The 12-mm glass slides were introduced into a homemade chamber and observed by imaging a series of consecutive overlapping optical sections with a Zeiss LSM510 confocal microscope. The thickness of the film was determined by measurement of the width of the green band (which corresponds to PLL-FITC) in computed orthogonal vertical sections through the imaged volumes (29). Both the GFP-expressing and the RFP-expressing E. coli strains were plated at an OD600 of 0.01 in PB medium and were observed after 30 min of incubation.
Scanning electron microscopy. After 30 min of incubation on a glass coverslip coated with the polyelectrolyte multilayer, the bacteria were fixed for 2 h at 4°C in 5% glutaraldehyde in 0.05 M cacodylate buffer at pH 7.4, rinsed in cacodylate buffer, postfixed in 1% osmium tetroxide, and then dehydrated in a series of increasing alcohol baths. Cells were observed with a Philips XL30 environmental scanning electron microscope.
Analysis of film growth and surface zeta potential. The PEI-(PSS-PAH)2-(PGA-PLL)n film construction process (where n corresponds to the number of PGA-PLL bilayers) and the insertion of defensin were monitored by optical waveguide light-mode spectroscopy (OWLS) (27, 34) and analysis with a quartz crystal microbalance (QCM) (20, 30). Briefly, OWLS is sensitive to the penetration depth of an evanescent wave through the film near the waveguide surface and gives access to the optical properties of the films. Details about the experimental setup and the procedure can be found elsewhere (28). The structure of the multilayers was analyzed by using the homogeneous and isotropic monolayer model, which allows the refractive index (nA) and the thickness (dA) to be determined. The amount of peptide adsorbed was calculated by the formula of De Feijter et al. (13): adsorbed mass = (dn/dc)1x (nA nC) x dA, where dn/dc is equal to 0.18 cm3/g and nC, which is the refractive index of the buffer, is equal to 1.3342.
At the beginning of the experiment, 100 µl of the PEI solution was manually injected into the measurement cell (37 µl). When a stable adsorption signal was obtained (after about 15 min), the NaCl buffer flow was started and was allowed to continue for about 10 min to rinse the excess material. In the same way, we continued with the alternate adsorption of PSS, PAH, and then PGA and PLL on the waveguide.
QCM (Q-Sense, Göteborg, Sweden) measures the changes in the resonance frequency of a quartz crystal when material is brought from solution. The crystal is excited at its fundamental frequency (about 5 MHz); and observations are made at the third, fifth, and seventh overtones (corresponding to 15, 25, and 35 MHz, respectively). The details of the experimental setup have been presented previously (28), except that the crystal used for the present study was coated with a thick (
100-nm) SiO2 film. The streaming potential method was also used to characterize the surface. Measurements were made on a homemade apparatus that has been described previously (24). The basic principle is to measure the pressure and the potential differences on both sides of a capillary (radius, 530 µm) made of fused silica by using two flasks containing four electrodes. Details about the procedure are given elsewhere (28). All polyelectrolytes as well as defensin were adsorbed in a 0.15 M NaCl solution, and measurements were performed after the rinsing of each layer.
|
|
|---|
f) monitored by the QCM technique (Fig. 2B) showed similar increases in thickness, with each layer contributing to an increase in the adsorbed mass on the crystal, thereby modifying the resonance frequency.
![]() View larger version (12K): [in a new window] |
FIG. 2. Construction of the polyelectrolyte multilayer film observed by OWLS (A) and from QCM measurements, with f equal to 15 Hz (B). Both techniques showed linear growth of the polyelectrolyte multilayer films during their formation.
|
![]() View larger version (15K): [in a new window] |
FIG. 3. Insertion of the defensin, followed by QCM measurements (A). The augmentation of f/ (where = 3 and f = 15 Hz) at the end of defensin deposition as well as the increase in the thickness of the film suggest protein adsorption. (B) Insertion of the defensin followed by streaming potential measurements. The surface charge stays anionic after the adsorption of the defensin.
|
150 mV). The buildup could then be further pursued. Taken together, the QCM, zeta potential, and OWLS measurements suggest the effective adsorption of defensin between the PGA and the PLL layers.
Antimicrobial activity of functionalized multilayer films. The activities of the defensin in both films in which the final layer is PLL and films in which the final layer is PGA were evaluated by use of defensin in the following architectures: PEI-(PSS-PAH)2-PGA-PLL-PGA-defensin-PLL for films in which the final layer is PLL or PEI-(PSS-PAH)2-PGA-PLL-PGA-defensin-PLL-PGA for films in which the final layer is PGA. The functionalized multilayer films were tested with two bacterial strains: M. luteus (a gram-positive organism) and E. coli (strain D22, a gram-negative organism). The activity of defensin in solution against these two strains is well described (37), with activities over ranges of concentrations from 0.75 to 1.5 µM against E. coli and 0.2 to 0.4 µM against M. luteus. In the layer buildup, defensin was adsorbed from a 10 µM concentrated solution, which was chosen to be 10 times higher than the MIC of the peptide in solution. Defensin retained its antimicrobial activity when it was inserted in the polyelectrolyte multilayer films, reducing the numbers of bacteria by 86.4% ± 7.97% for M. luteus (Fig. 4A) and 78.55% ± 11.55% for E. coli (Fig. 4B). As a control, the nonfunctionalized films in which the final layer was PLL reduced the number of bacteria by only 43.28% ± 15.31% for M. luteus and 8.23% ± 7.84% for E. coli, whereas films in which the final layer is PGA had no effect on E. coli (102.76% ± 13.39%) and very few effects on M. luteus (decrease in the number of bacteria, 18.44% ± 16.40%).
![]() View larger version (19K): [in a new window] |
FIG. 4. Antimicrobial assays. The results are expressed as a percentage of the results for the control ± standard deviation. The functionalized films showed a large capacity to reduce bacterial growth: 86.4% for M. luteus and 78.5% for E. coli D22 (***, P > 0.001). No effects were observed when the final layer was negatively charged with PGA. Def, defensin.
|
Modification of defensin concentration in multilayer films. In order to obtain higher levels of antimicrobial activity in the film, we tried to increase the amount of peptide adsorbed in the polyelectrolyte multilayer films. We therefore first increased the defensin concentration in solution during the construction of the film. No significant differences in the activities of films constructed with a peptide solution of 5, 10, 50, or 100 µM could be seen. In all cases, the effect measured against E. coli cultures was about 80%. This result could be attributed to peptide adsorption saturation on the polyelectrolyte layer. The increase in the peptide concentration in solution does not seem to modify the saturation level of the protein adsorption and therefore does not increase the antimicrobial efficiency of the film.
Several defensin layers were then deposited in the film architecture (Fig. 5). In fact, one of the major advantages of the multilayer technique is precisely that it allows the deposition of multiple layers of the proteins or the peptides tested. The number of peptide layers was increased by embedding the peptide in the following architecture: PEI-(PSS-PAH)2-(PGA-defensin-PLL)n, with n equal 1, 2, 5, or 10. In these experiments, the defensin concentration in solution was kept constant at 10 µM. As seen in Fig. 5, no significant differences could be observed between one or two defensin layers, but five layers of defensin significantly increased the antimicrobial activity (up to 90%). Even more interestingly, 10 layers of defensin brought the antimicrobial activity of the functionalized films to 98.75% (OD600 measurements with the values for the controls normalized to 100: control, 100 ± 5.4; 10 layers of defensin, 1.25 ± 0.31), which is the detection limit of our system. This clearly shows that a maximum antimicrobial effect can be reached simply by increasing the number of defensin layers deposited in the film.
![]() View larger version (13K): [in a new window] |
FIG. 5. Potential antimicrobial effect of the functionalized multilayer films, according to the number of peptide layers. No effect could be observed on films constructed with a defensin solution of 5, 10, 50, or 100 µM (data not shown). Nevertheless, the increase in the number of layers of defensin (in a 10 µM solution) increases the antimicrobial effect of the film up to 98.75% with 10 layers of defensin. *, P > 0.1; ***, P > 0.001; CTRL, control.
|
An observation confirming this hypothesis was obtained from confocal microscopy images of sections of the films in contact with the bacteria (Fig. 6A and B). From these confocal microscopy observations, it was found that the number of bilayers in the film had to be increased to about 20 (thickness at this stage,
1.6 µm). Moreover, E. coli strains were chosen to express RFP or GFP when they were placed on PLL-FITC- and PGA-TR-labeled films, respectively. The choice of two distinct colors allows observation of the films and the bacteria in two separate channels (green and red) and for the bacteria to be clearly distinguished over the films. The fact that PLL and PGA are both able to diffuse within the whole (PGA-PLL) film architecture (22) allows a clear visualization of the z sections of the films (either in the green channel, when PLL-FITC is used, or in the red channel, when PGA-TR is used). The lateral views of the films and the bacteria obtained by confocal laser scanning microscopy reveals that over a short period of time, the bacteria rarely come into contact with the films in which the final layer is PGA (Fig. 6A). On the other hand, the bacteria were often found to be in close contact with the film when PLL was the outermost layer and even seemed to partially penetrate the film architecture (Fig. 6B).
![]() View larger version (79K): [in a new window] |
FIG. 6. Bacterial adhesion as function of the final layer charge. (A and B) Confocal microscopy observations of relations between E. coli GFP and a film in which PGA-TR is the final layer (A) and E. coli RFP and a film in which PLL-FITC is the final layer (B). Note that the bacteria rarely come into contact with the film in which PGA is the final layer, while they were found to be in close contact with the film when PLL was the outermost layer. (C and D) Scanning electron microscopy observations of E. coli on a film in which PGA is the final layer (C) and a film in which PLL is the final layer (D). Note that on the film in which PLL is the final layer, the bacteria seem to be embedded in the multilayer structure (arrows). The removal of one bacterium (inset, panel D) reveals a clear impression in the multilayer film. Bars, 1 µm.
|
|
|
|---|
Alternatively, another method, which we have developed in the present study, is to protect these materials by attempting to kill the bacteria after they have adhered to the protected surface. Different techniques for the immobilization of an antimicrobial peptide at the surface have been described in the literature. For instance, Haynie et al. (18) covalently linked the carboxy-terminal amino acid of magainin with an ethylenediamine-modified polyamide resin. They demonstrated that immobilized peptides derived from the magainins eliminated all cells in growing cultures of gram-positive and gram-negative bacteria. Another technique was used for nisin, a small (3.3-kDa) peptide that is produced by the common milk bacterium Lactococcus lactis (25) and that is a member of a group of ribosomally produced peptides called "lantibiotics." These lantibiotics have been adsorbed onto polyvinyl chloride on silica surfaces and have maintained their activity, thereby killing microorganisms that adhered to the surface in vitro (3). Unfortunately, this method is based on the attachment of only one protein and suffers from this limitation. The mechanisms of resistance to nisin have already been described for E. coli, Salmonella, and Saccharomyces cerevisiae (14, 16).
An antimicrobial process based on a single protein will always be limited either by the antimicrobial spectrum of this peptide or by any new bacterial resistance. Insertion of proteins into polyelectrolyte multilayer films, however, is a technique that offers several major advantages. (i) It is a simple method. (ii) The method is not limited to a single type of peptide. Because no chemical modification is needed to embed the peptide, any antimicrobial peptide can be inserted. (iii) The method permits the peptide concentration to be increased by multiplication of the number of peptide layers. (iv) Antimicrobial peptide combinations can be used to enlarge the antimicrobial spectrum or to improve the efficiency against the same bacterial strain. The embedding of multiple peptides could constitute a way to increase the spectrum of protection and to prevent possible microbial resistance. From that perspective, other antimicrobial peptides, instead of the defensin used in this study, could be tested by the same approach, alone or in combination, in the polyelectrolyte multilayer films. For instance, cationic peptide antibiotics (such as polymyxin B, gramicidin D, gramicidin S, and the cathelicidins) could be good candidates for insertion in the films. Also, one may potentially multifunctionalize the film by inserting additional proteins or peptides that have other biological activities, such as anti-inflammatory molecules and adhesion peptides.
The biomedical applications of such antimicrobial interfaces are extremely diverse and are mainly linked to two factors: the biocompatibility of the multilayer films and the stability of the films in vivo. The cytotoxicity of the multiple layers has already been tested (35). In those experiments, the investigators evaluated the biocompatibility of the multilayers using human periodontal ligament cells or osteoblast-like cells (SaOS-2 cells). Different parameters, such as cell adherence, viability, growth, maintenance of the cellular phenotype, and the inflammatory response, were investigated. Good biocompatibility was found for films in which the final layer was PSS, PGA, or PLL. With respect to the stability of the films in vivo, preliminary fluorimetry and QCM experiments done in the laboratory have shown that these multilayer films are stable for more than 2 weeks in the presence of body fluids (e.g., blood or saliva). Moreover, the presence of fetal bovine serum (5% [vol/vol]) in the bacterial growth medium did not modify the antimicrobial activity of the functionalized films.
Therefore, the conjunction of good biocompatibility and the high degree of stability of polyelectrolyte multilayer films, together with the possibility of varying the number of adsorbed active proteins or peptides and their amounts, could lead to biomedical applications ranging from the protection of all the tools used for medical applications, such as catheter, needles, surgical tools, and tubes, to all types of materials that come into contact with wounds for a restricted period of time.
C.E. is grateful to the Faculty of Odontology of Strasbourg for financial support.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»